Navigation Links
Novel virus detection identifies new viruses in study of respiratory infections and asthma attacks
Date:9/6/2007

ronaviruses thought to be responsible for up to 15 percent of all colds in the United States was detectable in this study population. Instead, two newly described strains of coronaviruses dominated.

These findings are particularly important given the poor understanding of the role of viral diversity in RTIs and in asthma exacerbations. As a next step, Kistler suggested that future groups use the Virochip to continue to accumulate knowledge about such viruses. The range and depth of viral detection [using the Virochip] is significant, since gaining a comprehensive understanding of the viral pathogen diversity associated with asthma exacerbations may enable the development of specific strategies for treating or preventing asthma exacerbations caused by viral respiratory infection.

In an accompanying editorial, James E. Gern, MD and William W. Busse, MD of the University of Wisconsin School of Medicine and Public Health agreed that the Virochip assay could prove an excellent new tool for future studies looking to detect and understand novel viruses associated with respiratory illnesses.


'/>"/>

Contact: Steve Baragona
sbaragona@idsociety.org
703-299-0412
Infectious Diseases Society of America
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel antibiotic dressing developed for improved wound healing
3. A novel augmentation
4. Novel biopsy technique for prostate cancer
5. Novel computer model for breast cancer
6. Novel research on liver cancer
7. Novel way to fight cancer
8. Novel test for bowel cancer
9. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
10. Novel Therapy for Chronic Problem
11. Gene enchances radiation therapy - A novel approach to fight cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...FRANCISCO,Nov.25/PRNewswire/--TheBayAreaAirQuality... Spare the Air Alert forThursday,Nov...ogsoranyothersolidfuel,bothindoorsandoutdoors. ,...ualitytomorrow,"saidJackBroadbent,executiveofficer...pectthehealthoftheirneighborsandfellowcommunitymem...
(Date:11/25/2009)... survivors of testicular cancer who were treated w...ide effects, including neurological side effects a...reated with chemotherapy, according to a new study...he National Cancer Institute . , Marianne Brydy,...iversity Hospital, in Bergen, Norway, and colleagu...
(Date:11/25/2009)...itous discovery that grew out of a collaboration b...ally offer hope to the nearly 10 million Americans..., Also known as hardening of the arteries, perip...atory problem in which narrowed arteries reduce bl... a red flag for vascular disease, heart attack and...
(Date:11/25/2009)...ollow-up period was too short to draw definite con...ov. 25 (HealthDay News) -- In diabetic patients wi...no difference in outcomes at one year whether pati...enting, British researchers report. , Bypass su... patients with coronary artery disease. However, l...
(Date:11/25/2009)... Evaluation and treatment clinics to... Woodstock (Vocus) November 25, 2009 -- Centegra H...cines and H1N1 vaccine shots at four Centegra Prim...hipment of vaccine has arrived. The clinics are at... McHenry and will be open as follows: ,  ...
Breaking Medicine News(10 mins):Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...1, 2009 AMERIGROUP Corporation (NYSE: AGP ) t...r the fourth quarter ended December 31, 2008, befo.... At 8:30 a.m. Eastern Time on the same day, AMER...domestic) or 706-679-7245 (international) approxim...
...n observance of National Children,s Dental Health ... Association (PDA) is sponsoring its annual poster...re eligible to participate in the contest. , , T...lic libraries. In addition to the student prize, t...
...ould detect virus that can lead to failure, , ... urine test that can detect a common cause of kidn...nosis and treatment of patients with polyomavirus ...ems for people with compromised immune systems. Pe...
...ticle pollution correlate with increases in life e...y News) -- A new study shows there is a direct rel...tants in the air people breathe and life expectanc... meter of air adds about seven months of life expe...
...thy infant feeding can help stem the staggering ri...tate University nursing professor who will use a $...r infant feeding program. , Mildred Horodynski of...ces, known as infant-centered feeding. , Her thre...
...Pharmaceuticals, Inc. (Nasdaq: AMLN ) will webca...urth quarter and full year 2008 on Tuesday, Januar... Bradbury, Amylin,s president and chief executive ...08. , , The call will be webcast live through A...
Other Medicine News:Health News:AMERIGROUP Corporation to Discuss Fourth Quarter Earnings on February 19 2Health News:New Test May Help Kidney Transplant Patients 2Health News:Cleaner Air Equals Longer Life 2Health News:Cleaner Air Equals Longer Life 3Health News:MSU researcher receives $1.5 million grant for childhood obesity intervention study 2Health News:Amylin Pharmaceuticals to Webcast Year-End Results 2
(Date:11/24/2009)....24/PRNewswire-Asia/--ChindexInternational,Inc.,("...anproviderofWestern,healthcareproductsandservicesi...Companywillattendthe21stAnnualPiperJaffray,"Unplug...atthe,NewYorkPalaceHotel. , Managementiscurre...er1,2009,andholdone-on-onemeetingsthroughouttheday...
(Date:11/24/2009)...v.24/PRNewswire-FirstCall/--Endologix,Inc.(Nasdaq:...orticdisorders,announcedtodaythatithasfiledamotion...ingementlawsuitbroughtagainstitinOctober2009byCook...rtinIndianapolis,Indiana. ,, Endologixhasreques...tentandTrademarkOffice(USPTO)conductsproceedingsto...
(Date:11/24/2009)...ov.24/PRNewswire-FirstCall/--Vermillion,Inc.(VRML)...fReorganizationandDisclosureStatementtoday,Novembe...istrictofDelaware.AhearingtoconsiderapprovaloftheD...,2009,withthehearingontheconfirmationofthePlansche...panytopayallclaimsinfull.ThePlanisexpected,ifappro...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3InterMune to Release Third Quarter Financial Results on November 5 14645 1InterMune to Release Third Quarter Financial Results on November 5 14645 2Novavax Announces Poster Presentation at the 47th Annual Meeting of the IDSA 14642 1Novavax Announces Poster Presentation at the 47th Annual Meeting of the IDSA 14642 2MedCath Corporation to Hold Conference Call on Fourth Quarter Results 5826 1MedCath Corporation to Hold Conference Call on Fourth Quarter Results 5826 2
...aluate Safety, Efficacy of Novel Cortisol ...ept. 26 DiObex, Inc., a privately held,biotechnol...tics to treat,metabolic diseases, announced today ...inical trial of DIO-902, a novel cortisol synthesi...e 2 diabetes mellitus (T2DM). The Phase 2b multin...
...ive Nasal Spray Dosage form is Patient Friendly ...ry Delivery -, BOTHELL, Wash., Sept. 26 Nastech,...nced today the start of a,Phase 2 clinical trial e...,Spray in approximately 20 patients with type 2 di... evaluating formulations of Insulin Nasal Spray,as...
Other Medicine Technology:DiObex Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug 2DiObex Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug 3Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for Insulin Nasal Spray to Treat Diabetes 2Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for Insulin Nasal Spray to Treat Diabetes 3
Fixed Core Straight Safety Wire Guides - Standard (PTFE coated)
Fixed Core Straight Safety Wire Guides - Standard (stainless steel)
Fascial Incising Needles
Two-Part Trocar Needles - Standard
Medicine Products: